- Evan, G. and Littlewood, T. (1998) "A matter of life and cell death",Science 281, 1317-1321.
- Fisher, D.E. (1994) "Apoptosis in cancer therapy: crossing thethreshold", Cell 78, 539-542
- Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) "p53-dependent apoptosis modulates the cytotoxicity of anticancer agents", Cell 74, 957-967.
- Korsmeyer, S.J. (1992) "Bcl-2: A repressor of lymphocyte death",Immunol, Today 13, 285-288.
- Levine, A.J., Momand, J. and Finlay, C.A. (1991) "The p53 tumoursuppressor gene", Nature 351, 453-456.
- Melchers, F. and Rolink, A. (1999) "B-lymhocyte development and biology", In: Paul, E., ed, Fundamental Immunology (LippincottRaven, Philadelphia), pp 183-224.
- Surh, C.D. and Sprent, J. (1994) "T-cell apoptosis detected in situ during positive and negative selection in the thymus", Nature 372, 100-103.
- Clayton, L.K., Ghendler, Y., Mizoguchi, E., Patch, R.J., Ocain, T.D., Orth, K., Bhan, A.K., Dixit, V.M. and Reinherz, E.L. (1997) "T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection". EMBO J. 16, 2282-2293.
- Lang, J., Arnold, B., Hammerling, G., Harris, A.W., Korsmeyer, S., Russell, D., Strasser, A. and Nemazee, D. (1997) "Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells", J. Exp. Med. 186. 1513-1522.
- Andjelic, S. and Liou, H.C. (1998) "Antigen receptor-induced B lymphocyte apoptosis mediated via a protease of the caspase family", Eur. J. Immunol. 28, 570-581.
- Melamed, D. and Nemazee, D. (1997) "Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest", Proc. Natl. Acad. Sci. USA 94, 9267-9272.
- Martinez-Valdez, H., Guret, C., de Bouteiller, O., Fugier, L, Banchereau, J. and Liu, Y.J. (1996) "Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2", J. Exp. Med. 183. 971-977.
- Han, S., Zheng, B., Dal Porto, J. and Kelsoe, G. (1995) "In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance", J. Exp. Med. 182, 1635-1644.
- Adams, J.M. and Cory, S. (1998) "The Bcl-2 protein family: Arbiters of cell survival", Science 281, 1322-1326.
- Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B. and Korsmeyer, S.J. (1995) "Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death", Cell 80, 285-291.
- Motoyama, N., Wang, F., Roth, K.A., Sawa, H., Nakayama, K., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) "Massive cell death of immature bematopoietic cells and neurons in Bcl-x-deficient mice". Science 267, 1506-1510.
- Chao, D., Linette, G.P., Boise, L.H., White, L.S., Thompson, C.B. and Korsmeyer, S.J. (1995) "Bcl-xL and Bcl-2 repress a common pathway of cell death", J. Exp. Med. 182, 821-828.
- Veis, D.J., Sorenson, C.M., Shutter, J.R. and Korsmeyer, S.J. (1993) "Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosie, polycystic kidneys, and hypopigmented hair", Cell 75, 229-240.
- Nakayama, K-I., Nakayama, K., Negishi, L., Kuida, K., Shinkai, Y., Louie, M.C., Fields, L.E., Lucas, P.J., Stewart, V., Alt, F.W., et al. (1993) "Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice", Science 261, 1584-1588.
- Reed, J.C., Miyashita, T., Cuddy, M. and Cho, D. (1992) "Regulation of p26-bcl-2 protein levels in human peripheral blood lymphocytes", Lab. Invest. 67, 443-449.
- Kroemer, G., Zamzami, N. and Susin, A.S. (1997) "Mitochondrial control of apoptosis". Immunol. Today 18, 44-51.
- Zamzami, N., Marehetti, P. Castedo, M., Zanin, C., Vayssiere, J., Petit, X.P. and Kroemer, G. (1995) "Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo", J. Exp. Med. 181, 1661-1672.
- Bouchon, A., Krammer, P.H. and Walczak, H. (2000) "Critical role for mitochondria in B cell receptor-mediated apoptosis", Eur. J. Immunol. 30, 69-77.
- Kroemer, G. and Reed, J.C. (2000) "Mitochondrial control of death", Nature Med. 6, 513-519.
- Shimizu, S. and Tsujimoto, Y. (2000) "Proapoptotic BH3-only Bcl-2 family members induce cytochrome release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity", Proc.Natl.Acad. Sci USA 97, 577-582.
- Li, P., Nijhawan, D., Budihardjo, L, Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. (1997) "Cytochrome C and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade", Cell 91, 479-489.
- Susin, S.A., Zamzami, N., Marchetti, P., Hirsch, T., Gomes-Monterrey, L, Castedo, M. and Kroemer, G. (1996) "Bcl-2 inhibits the mitochondrial release of an apoptogenic protease", J. Exp. Med. 184, 1331-1341.
- Li, H., Zhu, H., Xu, C. and Yuan, J. (1998) "Cleavage of BID by caspase 8 mediate the mitochondrial damage in the Fas pathway of apoptosia", Cell 94, 491-501.
- Luo, X., Budihardjo, L, Zou, H., Slaughter, C. and Wang, X. (1998) "Bid, a Bcl-2 interacting protein, mediates cytochrome c release in response to activation of cell surface death receptors", Cell 94, 481-490.
- Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A. and Nagata, S. (1998) "A caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD", Nature 391,43-50.
- Sakahira, H., Enari, M. and Nagata, S. (1998) "Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis", Nature 391, 96-99.
- Liu, X., Zou, H., Slaughter, C. and Wang, X. (1997) "DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis". Cell 89, 175-184.
- Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, CM. (1985) "Involvement of the bcl-2 gene in human follicular lymphoma", Science 228, 1440-1443.
- Tsujimoto, Y., Bashir, M.M., Givol, L, Cossman, J., Jaffe, E. and Croce, C.M. (1987) "DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene", Proc. Natl. Acad. Sci. USA 84, 1329-1331.
- Zutter, M., Hockenbery, D., Silverman, G.A. and Korsmeyer, S.J. (1991) "Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms", Blood 78, 1062-1068.
- Adachi, M., Tafferi, A., Greipp, P.R., Kipps, T.J. and Tsujimoto, Y. (1990) "Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia", J. Exp. Med. 171, 559-564.
- Tashiro, S., Takechi, M., Asou, H., Takauchi, K., Kyo, T., Dohy, H., Kikuchi, M., Kamada, N. and Tsujimoto, Y. (1992) "Cytogenetic 2; 18 and 18; 22 translocation in chronic lymphocytic leukemia with juxtaposition of bcl-2 and immunoglobutin light chain genes", Oncogene 7, 573-577.
- Pepper, C., Hoy, T. and Bentley, D.P. (1997) "Bcl-2/Bax ratios in chronic lymphocytic leukemia and their correlation with in vitro apoptosis and clinical resistance", Br. J. Cancer 76, 935-938.
- Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J.C. and Lichtenstein, A. (1998) "BCL-X expression in multiple myeloma: possible indicator of chemoresistance", Cancer Res. 58, 256-262.
- Prokop, A., Wieder, T., Sturm, L, Essmann, F., Seeger, K., Wuchter, C., Ludwig, W.D., Henze, G., Dorken, B. and Daniel, P.T. (2000) "Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo", Leukemia 14, 1606-1613.
- Kuppers, R., Klein, U., Hansmann, M. and Rajewsky, K. (1999) "Cellular origin of human B-cell lymphomas", N.Eng. J. Med. 341, 1520-1529.
- Schlaifer, D., March, M., Krajewsld, S., Laurent, G., Prie, J., Delsol, G., Reed, J.C. and Brousset, P. (1995) "High expression of the bcl-x gene in Reed-Stemherg cells of Hodgkin's disease", Blood 85, 2671-2674.
- [43| Hansen, R. and Oren, M. (1997) "p53; From inductive signal to cellular effect", Curr. Opin. Genet. Dev. 7, 46-51.
- Yin, C., Knudson, C.M., Korsmeyer, S.J. and Van Dyke, T. (1997) "Bax suppresses tumorigenesis and stimulates apoptosis in vivo", Nature 385, 637-640.
- Zhan, Q., Fan, S., Bae, L., Guillouf, C., Liebermann, D.A., O'Connor, P.M., Fornace, A.J., et al. (1994) "Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis", Oncogene 9, 3743-3751.
- McCurrach, M.E., Connor, T.M., Knudson, C.M., Korsmeyer, S.J. and Lowe, S.W. (1997) "Bax-deficiency promotes drug resistance, oncogenic transformation by attenuating p53-dependent apoptosis". Proc. Natl. Acad. Sci. USA 94, 2345-2349.
- Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R. and Kley, N. (1995) "Induction of the growth inhibitor IGF-binding protein 3 by p53", Nature 377, 646-649.
- Ludwig, R.L., Bates, S. and Vousden, K.H. (1996) "Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function", Mol. Cell. Biol. 16, 4952-4960.
- Venot, C., Maratrat, M., Dureuil, C., Conseiller, E., Bracco, L. and Debussche, L. (1998) "The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression", EMBO J. 17,4668-4679.
- Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H. and Hotta, T. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma", N. Engl. J. Med. 337, 529-534.
- Dohner, H., Fiecher, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., et al (1995) "p53 gene deletion, predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias", Blood 85, 1580-1589.
- Gaidano, G., Ballerini, P., Gong, J.Z., lnghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. and Dalla-Favera, R. (1991) "p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia", Proc. Natl. Acad. Sci. USA 88, 5413-5417.
- Pinyol, M., Hernandez, L., Martinez, A., Cobo, F., Hernandez, S., Bea, S., Lopez-Guillermo, A., Nayach, I., Palacin, A., Nadal, A., Fernandez, P.L., Montserrat, E., Cardesa, A. and Campo, E. (2000) "INK4a/ARF locus alterations in human non-Hodgkin's lympho-mas mainly occur in tumors with wild-type p53 gene", Am. J. Pathol. 156, 1987-1996.
- Watanabe, T., Hotta, T., Ichikawa, A., Kinoshita, T., Nagai, H., Uchida, T., Murate, T. and Saito, H. (1994) "The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin", Blood 84, 3158-3165.
- Ashcroft, M. and Vousden, K.H. (1999) "Regulation of p53 stability", Oncogene 18, 7637-7643.
- Midgley, C.A., Desterro, J.M., Saville, M.K., Howard, S., Sparks, A., Hay, R.T. and Lane, D.P. (2000) "An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo", Oncogene 19, 2312-2323.
- Kuroki, J., Hirokawa, M., Kitabayashi, A., Lee, M. and Miura, A.B. (1996) "Cell-permeable ceramide inhibits the growth of TNF-a resistant B lymphoma cells by inducing GO/Gl arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis", Leukemia 10, 1950-1958
- Hirokawa, M., Kitabayashi, A., Kuroki, J. and Miura, A.B. (2000) "Induction of tissue factor production but not the upregulation of adhesion molecule expression by ceramide in human vascular endothelial cells", Tohoku J. Exp. Med. 191, 167-176.
- Kawabata, Y., Hirokawa, M., Kitabayashi, A., Horiuchi, T., Kuroki, J. and Miura, A.B. (1999) "Defective apoptotic signal transduction pathway downstream of caspase-3 in human B lymphoma cells: a novel mechanism of nuclear apoptosis resistance", Blood 94, 3523-3530.
- Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. and Lydon, N.B. (1996) "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcrabl positive cells", Nat. Med. 2, 561-566.
- Druker, B.J. and Lydon, N.B. (2000) "Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia", J. Clin. Invest. 105, 3-7.
- Amarante-Mendes, G.P., Kim, C.N., Liu, L., Huan, Y., Perkins, C.L., Green, D.R. and Bhalla, K. (1998) "Bcr-abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3", Blood 91, 1700 1705.
Dysregulation of Apoptosis and a Novel Mechanism of Defective Apoptotic Signal Transduction in Human B-cell Neoplasms
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.